Salut

Salut is an early-stage biotechnology company focused on the emerging field of muscle health and its impact on human longevity. Founded by technology and healthcare veterans, the company operates on the principle of "muscle as medicine," leveraging data-driven insights and biology to develop products that maintain and enhance muscle function throughout the aging process. Salut aims to address conditions such as sarcopenia and age-related frailty by targeting the underlying biological mechanisms of muscle maintenance. The company is currently in the pre-clinical stage, building a platform to identify and validate interventions that optimize muscle performance and metabolic health.